Ling Wong
Description
Dr. Ling Wong is a highly experienced venture capitalist, currently serving as the Founder and General Partner of both Highbury Group and Sea Lane Ventures. Based in Seattle, she brings a formidable track record spanning over two decades in the investment landscape. Prior to establishing her own firms, Dr. Wong held significant leadership roles at some of the industry's most prestigious venture capital funds. She was a General Partner at Lightspeed Venture Partners for six years, from 2014 to 2020, where she focused on enterprise software, AI, and fintech. Before Lightspeed, she spent seven years as a Partner at Kleiner Perkins Caufield & Byers, contributing to their investments in various technology sectors. Her career began at Intel Capital, where she honed her skills in corporate venture.
Through Highbury Group, Dr. Wong primarily focuses on seed-stage investments, targeting disruptive companies in areas such as artificial intelligence, SaaS, fintech, healthcare, and deep technology. Her investment thesis emphasizes backing exceptional founders who are leveraging cutting-edge innovation to solve complex problems and create new markets. Her extensive network and deep domain expertise, cultivated through her roles at top-tier firms, provide significant value-add to her portfolio companies, extending beyond capital to strategic guidance and operational support.
Dr. Wong's investment approach is characterized by a hands-on engagement with her portfolio companies, leveraging her operational background and technical acumen (holding a Ph.D. in Electrical Engineering from Stanford University). Her experience at Lightspeed and Kleiner Perkins involved significant investments in companies that have since become industry leaders, demonstrating her ability to identify high-potential ventures early on. As a Senior Advisor to Lightspeed Venture Partners, she maintains strong ties to the broader VC ecosystem, further enhancing her deal flow and co-investment opportunities for Highbury Group and Sea Lane Ventures. Her current vehicles allow her to provide focused, strategic capital to nascent companies poised for significant growth.
Investor Profile
Ling Wong has backed more than 32 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, Colombia.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $500K – $3M.
Stage Focus
- Seed (25%)
- Series A (19%)
- Series C (16%)
- Series B (16%)
- Series D (6%)
- Series E (6%)
- Series Unknown (3%)
- Series F (3%)
- Pre Seed (3%)
- Post Ipo Equity (3%)
Country Focus
- United States (97%)
- Colombia (3%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Health Insurance
- Biopharma
- Elder Care
- Software
- Life Science
- Elderly
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.